Arizona Clinical Trials is conducting research studies using investigational vaccines to determine if the study drug is effective in prevention of moderate or severe nausea, vomiting and diarrhea associated with norovirus. Participants will have 7 in person visits and up to 6 virtual appointments over the duration of the study (25 months).